# PharMerica CORP

PharMerica CORP is a company headquartered in Louisville, KY, United States.

## Company overview

- **Legal name:** PharMerica CORP
- **Former names in filing history:** SAFARI HOLDING CORP (2007-03-26 to 2007-07-17)
- **Classification:** Company
- **Industry (SIC):** 5912 — Retail-Drug Stores and Proprietary Stores
- **Headquarters:** Louisville, KY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001388195

## About

PharMerica CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388195, and its reported industry is Retail-Drug Stores and Proprietary Stores. In 10-K filed on 2017-02-24, it reported annual revenue of USD 2,091,100,000; net income of USD 21,600,000; total assets of USD 1,299,500,000 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $2.1B (USD 2,091,100,000)
- **Net income:** $21.6M (USD 21,600,000)
- **Total assets:** $1.3B (USD 1,299,500,000)
- **Cash and equivalents:** $5.4M (USD 5,400,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $2.0B (USD 2,028,500,000)
- **Net income:** $35.1M (USD 35,100,000)
- **Total assets:** $1.2B (USD 1,153,700,000)
- **Cash and equivalents:** $23.1M (USD 23,100,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $1.9B (USD 1,894,500,000)
- **Net income:** $6.8M (USD 6,800,000)
- **Total assets:** $1.1B (USD 1,068,100,000)
- **Cash and equivalents:** $33.3M (USD 33,300,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $1.8B (USD 1,757,900,000)
- **Net income:** $18.9M (USD 18,900,000)
- **Total assets:** $901.4M (USD 901,400,000)
- **Cash and equivalents:** $24.2M (USD 24,200,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2017-12-07 — period 2017-12-07 — 8-K
- Form 8-K — filed 2017-11-09 — period 2017-11-09 — 8-K
- Form 10-Q — filed 2017-11-09 — period 2017-09-30
- Form 8-K — filed 2017-11-09 — period 2017-11-09 — FORM 8-K
- Form 8-K — filed 2017-10-27 — period 2017-10-27 — FORM 8-K
- Form 8-K — filed 2017-08-28 — period 2017-08-25 — FORM 8-K
- Form 8-K — filed 2017-08-03 — period 2017-08-01 — FORM 8-K
- Form 8-K — filed 2017-08-02 — period 2017-08-02 — FORM 8-K
- Form 10-Q — filed 2017-08-02 — period 2017-06-30
- Form 8-K — filed 2017-08-02 — period 2017-08-01 — FORM 8-K
- Form 8-K — filed 2017-06-19 — period 2017-06-14 — 8-K
- Form 10-Q — filed 2017-05-10 — period 2017-03-31

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/pharmerica-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology